PlainRecalls

Ion Beam Applications S.a.

36 recalls on record · Latest: Mar 18, 2026

Subscribe to new Ion Beam Applications S.a. recalls (RSS)

Agency notice ledger

Federal filing book Ion Beam Applications S.a. MID-BOOK · SINGLE-AGENCY

#473 of 14,151 · 36 notices · 0.034% archive

  • BOOK 36 notices
  • RANK #473 of 14,151
  • SHARE 0.034% archive
  • AGENCY FDA Devices (36)
  • CAT medical devices
  • CATS 1 category
  • LATEST Mar 18, 2026
  • PHOTO Advanced Sterilizatio…

Nearest notice-volume peer: Advanced Sterilization Products (0 notice gap)

Ion Beam Applications S.a. accounts for about 0.034% of the 104,423-notice archive on 36 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Ion Beam Applications S.a. compares to 14,151 recalling firms

Ion Beam Applications S.a. ranks 473rd of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Ion Beam Applications S.a. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

36 473rd of 14151 higher than 13,667 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Ion Beam Applications S.a. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Ion Beam Applications S.a. holds about 0.034% of archive notices alongside 36 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Devices Moderate Mar 18, 2026

IBA Proton Therapy System - PROTEUS 235

FDA Devices Moderate Sep 18, 2024

IBA Proton Therapy System - PROTEUS 235 ProteusPLUS and ProteusONE Software versions: PTS-8 versions, PTS-10 versions, PTS-11 versions, and PTS-12 versions

FDA Devices Moderate Aug 28, 2024

IBA Proton Therapy System - PROTEUS 235- Designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation

FDA Devices Moderate Jun 12, 2024

IBA Proton Therapy System - PROTEUS 235 - Designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.

FDA Devices Moderate May 1, 2024

IBA Proton Therapy System - PROTEUS 235, PTS-10 versions, PTS-11 versions, and PTS-12 versions.

FDA Devices Moderate Nov 22, 2023

IBA Proton Therapy System - PROTEUS 235. PTS-11 versions, PTS-12 versions with Orion PPS version OSS6.0. Configured with Orion Patient Positioning System.

FDA Devices Moderate Jun 8, 2022

Proteus235- Proton Therapy System: to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation

FDA Devices Moderate Mar 16, 2022

ProteusPLUS and ProteusONE- designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation Proteus 235

FDA Devices Moderate Jan 19, 2022

Proteus 235; Version: PTS-8 versions before PTS-8.7.2

FDA Devices Moderate Sep 15, 2021

Proteus 235- designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation

FDA Devices Moderate Aug 4, 2021

Proteus 235-Proton Therapy System

FDA Devices Moderate Aug 19, 2020

Proteus 235 The Proton Therapy System - Proteus 235 (brand names: Proteus Plus and Proteus ONE) is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.

FDA Devices Moderate Aug 5, 2020

Proteus 235 The Proton Therapy System - Proteus 235 (brand names: Proteus Plus and Proteus ONE) is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.

FDA Devices Moderate Jan 16, 2019

Proteus 235 Product Usage: The Proton Therapy System - Proteus 235 (brand names: Proteus Plus and Proteus ONE) is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation localized to the head and neck.

FDA Devices Moderate Jul 25, 2018

Proteus 235, Universal Nozzle with snout 300x400; PBS dedicated nozzle with snout XL Product Usage: Device is designed to produce and deliver proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation localized to the head and neck.

FDA Devices Moderate Jul 18, 2018

Proteus 235, Version PTS-11.0.1.2 and PTS-11.0.2 Product Usage: A device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.

FDA Devices Moderate Jul 4, 2018

The Proton Therapy System - Proteus 235 (brand names: Proteus Plus and Proteus ONE) Proteus 235, Beam Management System (PBS)

FDA Devices Moderate Jun 20, 2018

Proteus ONE and Proteus Plus

FDA Devices Moderate Jun 20, 2018

12C

FDA Devices Moderate Jun 20, 2018

Proteus 235 The PTS is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation localized to the head and neck.

FDA Devices Moderate Jun 13, 2018

12C (AdaPTinsight) Affected component: AdaPTinsight software Product Usage: 12C is used with a charged particle or photon radiation therapy system for localization of the patient position with respect to the therapy equipment and to provide correction feedback to the radiation therapy system.

FDA Devices Moderate May 2, 2018

Proteus 235, ProteusPLUS or Proteus ONE produces and delivers a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.

FDA Devices Moderate Mar 21, 2018

Proteus 235, Pencil Beam Scanning, PTS-9.4.X, PTS-10.0.1.1 The Proton Therapy System - Proteus 235 (brand names: Proteus Plus and Proteus ONE) is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation lo

FDA Devices Moderate Mar 21, 2018

Proteus 235, Proton Therapy System a medical device designed to produce and delivers a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.

FDA Devices Moderate Mar 21, 2018

Proteus 235, Uniform and Pencil Beam Scanning The Proton Therapy System - Proteus 235 (brand names: Proteus Plus and Proteus ONE) is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation localized to th

FDA Devices Moderate Mar 14, 2018

Proteus 235, Pencil Beam Scanning version PTS-6.4.11.X The Proton Therapy System - Proteus 235 (brand names: Proteus Plus and Proteus ONE) is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation locali

FDA Devices Moderate Mar 14, 2018

Proteus 235, graphite block 8

FDA Devices Moderate Jul 12, 2017

Proteus 235, Proton Therapy System Product Usage: The Proton Therapy System - Proteus 235 is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation localized to the head and neck.

FDA Devices Moderate Jul 12, 2017

Proteus 235 and Proteus ONE proton therapy systems

FDA Devices Moderate Jun 28, 2017

Proteus 235

FDA Devices Moderate May 24, 2017

Proton therapy system -Proteus 235 aka Proteus Plus. A medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.

FDA Devices Moderate Apr 26, 2017

Proteus 235, Proton Therapy System

FDA Devices Moderate Apr 5, 2017

Proteus 235

FDA Devices Moderate Dec 31, 2014

adaPT insight (12C), v1.3.2, PAT.109 (US), Treatment room 4: I2C is used with a charged particle or photon radiation therapy system for localization of the patient position with respect to the therapy equipment and to provide correction feedback to the radiation therapy device.

FDA Devices Moderate Nov 5, 2014

Proteus 235 Proton Therapy System for cancer treatment.

FDA Devices Moderate Apr 30, 2014

Proteus 235 Proton Therapy System Legacy Software version 7.2.7 and higher, models 110, 112, 113, and 116. Proton therapy

Ion Beam Applications S.a. holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Frequently Asked Questions

How many federal recall notices name Ion Beam Applications S.a.?
PlainRecalls indexes 36 distinct federal recall events naming Ion Beam Applications S.a., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Ion Beam Applications S.a. sit among other recalling firms?
Ion Beam Applications S.a. ranks #473 of 14,151 by distinct recall-event count among 14,151 firms in this archive (97th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Ion Beam Applications S.a.'s notices?
FDA Devices accounts for 36 of this firm's 36 indexed notices.
What product category dominates Ion Beam Applications S.a.'s filing book?
Filings for Ion Beam Applications S.a. span 1 product category, led by medical devices. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous?
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Ion Beam Applications S.a.: 36 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Devices). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Ion Beam Applications S.a.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026